Zymeworks Inc. (ZYME) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.8 billion, Zymeworks Inc. is a small-cap company. The stock currently trades at $23.31, up 0.09% today, with a 52-week range of $9.03–$28.49. The company trades at a forward P/E of 84.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.08 | $-1.08 | +33.3% | |
| 2024 | $-1.62 | $-1.62 | +5.8% | |
| 2023 | $-1.72 | $-1.72 | -190.5% | |
| 2022 | $1.90 | $1.91 | — |